Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2020

View Archived Issues

BeyondSpring submits patent application for BPI-002 as antiviral treatment

Virometix receives approval to initiate phase I study of V-306

Phase I results for vesatolimod in HIV controllers

First-in-human data for AAV8-coRPGR gene therapy

New mouse model of Charcot arthropathy

GARDP and Daiichi Sankyo partner for the discovery of new antibiotics

Medicago announces advances in the production of vaccine candidate for COVID-19

PLX cells to be developed for the potential treatment of complications caused by COVID-19

Positive results presented from phase Ib portion of PREVAIL study of PRV-3279

5-Hydroxymethylcytosine is a marker in classical Hodgkin's lymphoma

AbbVie receives EC approval of Venclyxto plus obinutuzumab for adults with CLL

Obschestvo S Ogranichennoi Otvetstvennostiyu "Z Therapeutics" divulges GC inhibitors

Roche patents Toll-like receptor antagonists

Mirati Therapeutics and Array BioPharma identify KRAS mutant inhibitors

Arcus Biosciences presents new CD73 inhibitors

Phase II data reported for RP-101 in moderate-to-severe DED

New mouse model with reduced editing in AMPA receptor GluA2(Q) site to study CNS disorders

Cytokinetics describes new cardiac myosin inhibitors

KIF15, MAD1L1 and DEPTOR expression are associated with susceptibility to IPF, large GWAS shows

First patient dosed in phase II study of HLX-10 plus chemotherapy in advanced cervical cancer

AbCellera and Eli Lilly establish collaboration to codevelop antibody products for COVID-19

Dual PMIX/PMX inhibitor WM-382 clears malaria parasites in vivo

CROI 2020: For beating HIV, how good is best?

Emergent BioSolutions begins development of hyperimmune-based candidates for COVID-19

Chinese trial studies utility of ASC-09F for COVID-19 pneumonia

ART-24 begins phase I trial for prevention of recurrence of C. difficile infection

FDA approves Opdivo plus Yervoy for the treatment of HCC previously treated with sorafenib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....